Biotest | Evaluate

Private equity cleans up Sanofi’s failed generics foray

August 10, 2016

Why Abbvie might think twice before exercising Ablynx option

December 09, 2011

Pharmacyclics strikes most lucrative single-product deal of 2011

August 05, 2011

Conventional products remain the core for deal makers

July 26, 2011

Glaxo emerges as big spender as external pipeline grows

July 26, 2011

Therapeutic focus - Long-acting haemophilia agents set to shake things up

July 15, 2011

Therapeutic focus - Antibody drug conjugates still making slow progress

April 26, 2010

Shares in plasma companies bleeding value over slowdown fears

December 01, 2009

Event - ImmunoGen's antibody drug conjugates shaping up for scrutiny

April 28, 2009

Pandemic threat prompts surge of speculative investments

August 07, 2008

Companies on the way to being 2008's winners and losers - European focus

Load More